1. Japan Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: major
Elan Corp.

Elan Corp.

722.00
JPY
+3.00
(+0.42%)
42.85EPS
20.84P/E
53.99BMarket Cap
Oct 30Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
125.52
151.17
153.62
193.68
260.02
309.04
355.1
429.98
522.77
599.81
685.18
785.75
916.95
- -
Basic EPS, GAAP
5.16
5.24
6.19
8.5
11.06
14.39
16.33
23.87
31.49
34.45
41.66
38.94
45.77
- -
Free Cash Flow per Basic Share
5.05
4.65
4.44
5.95
4.09
18.1
11.7
30.7
33.52
20.41
26.22
59.6
52.06
- -
Dividend per Share
0.23
0.24
0.31
0.75
1.5
1.99
3.49
4.5
6.87
9.18
11.01
13.03
13.03
- -
Book Value per Share
14.47
35.98
41.73
49.21
58.48
70.34
82.86
102.05
123.78
148.69
178.86
206.77
238.8
- -
Tangible Book Value per Share
14.34
35.5
41.04
48.35
54.68
66.4
79.62
99.37
122.04
147.16
177.06
190.02
207.42
- -
Basic Weighted Avg Shares
48
49
59
59
59
60
61
61
61
60
60
60
60
60
Sales/Revenue/Turnover
6,025
7,464
9,011
11,408
15,467
18,585
21,519
26,056
31,636
36,265
41,426
47,514
55,449
- -
Operating Margin (%)
6.68
5.81
6.53
6.45
5.9
6.88
6.94
7.94
8.85
9.35
8.85
7.52
7.71
- -
Depreciation Expense
33
28
29
34
80
100
110
117
120
143
188
919
1,349
- -
Net Income, GAAP
248
259
363
501
658
865
990
1,446
1,906
2,083
2,519
2,355
2,768
- -
Effective Tax Rate (%)
38.22
40.42
36.54
33.21
30.81
32.52
34.09
32.68
32.38
31.38
31.59
33.53
32.38
- -
Profit Margin (%)
4.11
3.47
4.03
4.39
4.25
4.66
4.6
5.55
6.02
5.74
6.08
4.96
4.99
- -
Working Capital
683
1,786
2,115
2,498
2,896
3,431
4,116
4,678
5,713
7,064
7,418
7,954
7,481
- -
LT Debt
191
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
77
366
- -
Total Equity
810
2,110
2,457
2,921
3,497
4,263
5,021
6,184
7,484
8,990
10,814
12,502
14,682
- -
Return on Invested Capital (%)
- -
14.85
15.1
17.07
18.4
20.55
19.48
22.56
24.86
25.78
23.44
18.97
19.27
- -
Return on Capital (%)
- -
16.42
15.82
18.62
20.5
22.31
21.32
25.82
27.89
25.29
25.44
20.14
19.55
- -
Return on Common Equity (%)
- -
17.73
15.9
18.62
20.5
22.31
21.32
25.82
27.89
25.29
25.44
20.2
20.54
- -

Capital Structure

JPY

•

in mil. unless spec.
Jun'24
Mar'26
Jun'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
60
60
60
Market Capitalization
53,992
43,548
45,002

Working Capital

JPY

•

in mil. unless spec.
Jun'24
Mar'26
Jun'26
Total Current Assets
15,702
- -
- -
Cash, Cash Equivalents & STI
5,282
- -
- -
Accounts Receivable, Net
5,133
- -
- -
Inventories
1,750
- -
- -
Total Current Liabilities
7,849
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
19.59%
18.89%
17.44%
Free Cash Flow
59.15%
22.6%
-12.65%
Net Income, GAAP
23.44%
14.6%
17.54%
Sales/Revenue/Turnover
20.09%
16.33%
16.7%
Total Cash Common Dividend
50.71%
24.88%
-0.05%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
11,487
11,358
- -
- -
47,514
2025
- -
- -
- -
- -
55,449
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
12.02
9.9
- -
- -
38.94
2025
- -
- -
- -
- -
45.77
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
13.03
2025
- -
- -
- -
- -
13.03
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Tomohiro Minesaki
Full Time Employees
974
Sector
Health technology
Industry
Pharmaceuticals: major
Address
15-12 Idegawa Town Matsumoto NA Japan 390-0826
IPO Date
Nov 7, 2014
Website
kkelan.com
Similar Companies
Eli Lilly and Company (NYSE:LLY)
Novo Nordisk A/S (NYSE:NVO)
Johnson & Johnson (NYSE:JNJ)
Pfizer, Inc. (NYSE:PFE)
Dr. Reddy's Laboratories Ltd. (NSE:DRREDDY)
Divi's Laboratories Limited (NSE:DIVISLAB)
Business
Elan Corporation (TSE: 6099) provides nursing care and healthcare-related services primarily in Japan, specializing in hospitalization support sets known as CS Sets that include rental with laundry services for clothing, towels, diapers, and daily necessities for patients in hospitals and nursing care facilities such as geriatric health care facilities, special nursing homes for the elderly, fee-based nursing homes, group homes, and care houses; it also offers optional services including hospitalization and nursing care expenses guarantee through CS Set R service, trouble guarantee via CS Set LC service, original patient clothing brand lifte, clothing rental for stays under Smile Wear, and an online mail-order shop for nursing care products. Founded in 1995 and headquartered in Matsumoto, Nagano Prefecture, Japan, the company operates from 28 head offices and sales branches nationwide, serving 428,000 users across 2,320 contracted facilities with a 15.0% market penetration, the highest in the industry, and extends operations into Southeast Asia including Vietnam through subsidiaries like TMC Viet Nam Trading and Service Joint Stock Company, alongside group companies such as ELAN COULEUR Corporation, ELAN LOGISTICS Corporation, and GREEN LAUNDRY Joint Stock Company. In recent developments, Elan became a consolidated subsidiary of M3 Inc. (TSE: 2413) following the successful tender offer (TOB) completed on October 21, 2024, at JPY 1,040 per share, with M3 acquiring over 33 million shares to combine resources for cross-selling, new business creation, CS Set enhancements, competitive strengthening, and overseas expansion support; additionally, it increased its stake in Classico, a white coat developer, to 41.3% with 14.9% voting rights as of June 2024, and pursued investments in India including BIHS with Toppan Printing and MSI for hospital e-commerce, Quick Smart Wash Pvt. Ltd. in 2021 for in-hospital laundry, and Akal Information Systems Ltd. in 2023 for IT staffing, while achieving 17 consecutive years of sales and profit growth with FY2024 sales of JPY 47,513 million and 1,150 employees.